Merck’s earnings miss focused attention on Gardasil. The real issue is Keytruda

Taking stock of the drug industry, from the lab to the medicine chest

February 4, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Wong Maye-E/AP STAT+ | International monitor allows monkey shipments from Cambodia to continue The Cambodian government now has time to take steps to ensure macaques that are shipped internationally have been bred in captivity. By Ed Silverman STAT+ | Merck's earnings miss focused attention on Gardasil. The real issue is Keytruda The cancer drug will lose its patent exclusivity in 2028. And it could face lower reimbursement from Medicare under the Inflation Reduction Act before that. By Matthew Herper RFK Jr. likely to win confirmation to top Trump health role as key GOP senator says he'll vote yes Sen. Bill Cassidy says RFK Jr. won his support after the HHS nominee made commitments to protect vaccines. By John Wilkerson, Isabella Cueto, Rachel Cohrs Zhang, and Lizzy Lawrence

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser